| 2024-05-07 | -62.9% | legal | SEC EDGAR | TMCI 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-11-07 | -44.5% | earnings | Seeking Alpha | Treace Medical plunges despite Q3 beat; BTIG downgrades on guidance cut |
| 2025-11-07 | -44.5% | earnings | Seeking Alpha | Treace Medical revises 2025 revenue guidance to $211M-$213M as demand shifts and new products expand market reach |
| 2025-11-07 | -44.5% | earnings | Seeking Alpha | Treace Medical Concepts, Inc. (TMCI) Q3 2025 Earnings Call Transcript |
| 2025-11-07 | -44.5% | analyst | Investing.com | JPMorgan downgrades Treace Medical stock rating to Underweight amid market headwinds - Investing.com |
| 2025-11-07 | -44.5% | earnings | Seeking Alpha | Treace Medical down after Q3; BTIG downgrades (TMCI:NASDAQ) - Seeking Alpha |
| 2023-11-09 | -42.8% | legal | SEC EDGAR | TMCI 8-K: 2.02 and (SEC Filing) |
| 2023-11-10 | -41.2% | news | CNN | symbol__ Stock Quote Price and Forecast - CNN |
| 2024-11-05 | +39.6% | earnings | Seeking Alpha | Treace Medical Concepts GAAP EPS of -$0.25 beats by $0.02, revenue of $45.08M beats by $1.6M |
| 2024-11-05 | +39.6% | legal | SEC EDGAR | TMCI 8-K: 2.02 and (SEC Filing) |
| 2024-11-06 | +33.9% | earnings | Seeking Alpha | Treace Medical Concepts, Inc. (TMCI) Q3 2024 Earnings Call Transcript |
| 2026-04-10 | +30.5% | news | The Globe and Mail | Treace Medical Concepts Announces Leadership Transition and Outlook - The Globe and Mail |
| 2026-04-09 | +28.8% | legal | SEC EDGAR | TMCI 8-K: 2.02, 5.02and7.01 (SEC Filing) |
| 2026-04-09 | +28.8% | news | Stock Titan | Treace Medical (NASDAQ: TMCI) raises 2026 sales view as CCO departs - Stock Titan |
| 2026-04-09 | +28.8% | earnings | Cổng thông tin điện tử tỉnh Tây Ninh | How does earnings affect Treace (TMCI) Stock | Price at $1.50, Up 6.79% - Analyst Downgrade - Cổng thông tin điện tử tỉnh Tây Ninh |
| 2025-11-06 | -27.6% | earnings | Seeking Alpha | Treace Medical Concepts GAAP EPS of -$0.26 beats by $0.02, revenue of $50.2M beats by $0.6M |
| 2025-11-06 | -27.6% | legal | SEC EDGAR | TMCI 8-K: 2.02, 5.02 (SEC Filing) |
| 2025-11-06 | -27.6% | earnings | Yahoo Finance | Treace Medical Concepts (TMCI) Reports Q3 Loss, Beats Revenue Estimates - Yahoo Finance |
| 2023-03-07 | +22.5% | legal | SEC EDGAR | TMCI 8-K: 2.02 and (SEC Filing) |
| 2025-11-08 | -21.8% | news | simplywall.st | Is Treace Medical Concepts (NASDAQ:TMCI) Using Too Much Debt? - simplywall.st |
| 2026-02-27 | -20.5% | earnings | GuruFocus.com | Treace Medical Concepts Inc (TMCI) Q4 2025 Earnings Call Highlights: Navigating Challenges with ... |
| 2026-02-27 | -20.5% | earnings | MarketBeat | Treace Medical Concepts Q4 Earnings Call Highlights |
| 2026-02-27 | -20.5% | earnings | Seeking Alpha | Treace Medical signals 2026 revenue target of $200M–$212M while expanding comprehensive bunion solutions |
| 2026-02-27 | -20.5% | earnings | Seeking Alpha | Treace Medical Concepts, Inc. (TMCI) Q4 2025 Earnings Call Transcript |
| 2026-02-27 | -20.5% | earnings | Seeking Alpha | Treace Medical Concepts GAAP EPS of -$0.15 in-line, revenue of $62.5M beats by $0.63M |
| 2026-02-27 | -20.5% | legal | SEC EDGAR | TMCI 8-K: 2.02 and (SEC Filing) |
| 2026-02-27 | -20.5% | earnings | Yahoo Finance | Treace Medical Concepts Q4 Earnings Call Highlights - Yahoo Finance |
| 2026-02-27 | -20.5% | earnings | Investing.com | Earnings call transcript: Treace Medical Concepts Q4 2025 reports revenue decline, stock edges up - Investing.com |
| 2026-02-27 | -20.5% | legal | TradingView | TREACE MEDICAL CONCEPTS, INC. SEC 10-K Report - TradingView |
| 2026-02-27 | -20.5% | earnings | Investing.com | Treace Medical Concepts earnings missed, revenue topped estimates - Investing.com |
| 2024-11-04 | +19.5% | news | Stock Titan | Treace Comments on CMS’ 2025 Final Rule for Hospital Outpatient and ASC Settings - Stock Titan |
| 2023-08-08 | -15.8% | legal | SEC EDGAR | TMCI 8-K: 2.02 and (SEC Filing) |
| 2026-04-13 | +15.5% | news | Simply Wall St. | Akebia Therapeutics Leads The Pack Of 3 Promising Penny Stocks |
| 2026-03-02 | -14.8% | analyst | MT Newswires | Truist Securities Adjusts Treace Medical Concepts PT to $2 From $3, Maintains Hold Rating |
| 2024-01-08 | +11.9% | legal | SEC EDGAR | TMCI 8-K: 2.02 and (SEC Filing) |
| 2025-08-08 | +11.9% | earnings | Seeking Alpha | Treace Medical anticipates 7–10% revenue growth in 2025 while launching next-gen bunion solutions |
| 2025-08-08 | +11.9% | earnings | Seeking Alpha | Treace Medical Concepts, Inc. (TMCI) Q2 2025 Earnings Call Transcript |
| 2024-05-15 | +11.6% | M&A | Yahoo Finance | Director Jane Kiernan Acquires 19,356 Shares of Treace Medical Concepts Inc (TMCI) - Yahoo Finance |
| 2025-08-07 | +11.4% | earnings | Seeking Alpha | Treace Medical Concepts GAAP EPS of -$0.28 beats by $0.01, revenue of $47.39M beats by $0.31M |
| 2025-08-07 | +11.4% | legal | SEC EDGAR | TMCI 8-K: 2.02 and (SEC Filing) |
| 2026-04-08 | +11.0% | news | Zacks | Artivion (AORT) Soars 5.3%: Is Further Upside Left in the Stock? |
| 2026-04-08 | +11.0% | earnings | MarketBeat | Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives Average Recommendation of "Reduce" from Analysts - MarketBeat |
| 2026-02-28 | -10.8% | earnings | Moby | Treace Medical Concepts, Inc. Q4 2025 Earnings Call Summary |
| 2026-02-28 | -10.8% | earnings | simplywall.st | Treace Medical Concepts Q4 Loss Narrowing Challenges Persistent Bearish Narratives On Profitability - simplywall.st |
| 2022-05-05 | -10.3% | legal | SEC EDGAR | TMCI 8-K: 2.02 and (SEC Filing) |
| 2025-01-13 | +9.4% | earnings | Seeking Alpha | Treace Medical Concepts reports Q4 preliminary revenue of $68.4M - $68.8M |
| 2025-01-13 | +9.4% | legal | SEC EDGAR | TMCI 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-12-01 | -9.1% | news | GlobeNewswire | Johnson Fistel, PLLP Investigates Claims on Behalf of - GlobeNewswire |
| 2026-04-06 | -8.1% | news | Stock Titan | Treace Medical Concepts (NASDAQ: TMCI) details 2026 virtual annual meeting, votes - Stock Titan |
| 2026-04-06 | -8.1% | legal | Stock Titan | [ARS] TREACE MEDICAL CONCEPTS, INC. SEC Filing - Stock Titan |
| 2026-04-06 | -8.1% | news | Cổng thông tin điện tử Tỉnh Sơn La | Is Treace (TMCI) Stock Trending Down | Price at $1.43, Down 1.38% - Technical Analysis - Cổng thông tin điện tử Tỉnh Sơn La |
| 2025-02-27 | -7.8% | earnings | Seeking Alpha | Treace Medical Concepts GAAP EPS of -$0.01 beats by $0.03, revenue of $68.7M beats by $1.51M |
| 2025-02-27 | -7.8% | legal | SEC EDGAR | TMCI 8-K: 2.02 and (SEC Filing) |
| 2026-02-09 | -7.7% | analyst | Yahoo Finance | Stifel Revises Treace Medical Concepts, Inc. (TMCI) Price Target in Sector-Wide Update - Yahoo Finance |
| 2026-01-23 | -7.6% | news | DirectorsTalk Interviews | Treace Medical Concepts, Inc. (TMCI) Stock Analysis: Exploring A Potential 81% Upside - DirectorsTalk Interviews |
| 2021-08-12 | -7.5% | earnings | Zacks Investment Research | What date does Treace Medical Concepts's (TMCI) report Earnings - Earnings Calendar & Announcement - Zacks Investment Research |
| 2025-05-13 | -7.4% | executive | simplywall.st | We Discuss Why Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) CEO Compensation May Be Closely Reviewed - simplywall.st |
| 2022-05-04 | -7.3% | legal | SEC EDGAR | TMCI 8-K: 1.01, 1.02, 2.03 (SEC Filing) |
| 2025-11-11 | -6.9% | news | Seeking Alpha | Treace Medical Concepts, Inc. (TMCI) Presents at UBS Global Healthcare Conference 2025 Transcript |
| 2024-08-07 | -6.7% | earnings | Seeking Alpha | Treace Medical Concepts Inc (TMCI) Q2 2024 Earnings Call Transcript |
| 2025-04-07 | -6.6% | news | Seeking Alpha | Treace Medical Concepts: No Solid Footing |
| 2025-04-07 | -6.6% | news | Seeking Alpha | Treace Medical Concepts names John Treace as chair |
| 2025-04-07 | -6.6% | executive | Seeking Alpha | Treace Medical appoints John Treace as chairman of the board |
| 2025-04-07 | -6.6% | legal | SEC EDGAR | TMCI 8-K: 5.02 and (SEC Filing) |
| 2025-04-07 | -6.6% | news | Seeking Alpha | Treace Medical Concepts: No Solid Footing (NASDAQ:TMCI) - Seeking Alpha |
| 2026-03-19 | -6.2% | analyst | Yahoo Finance | How The Story Is Shifting For Treace Medical Concepts (TMCI) After Analyst Target Resets - Yahoo Finance |
| 2025-11-17 | -6.2% | news | Trefis | Day 10 of Loss Streak for Treace Medical Concepts Stock with -56% Return (vs. -61% YTD) [11/17/2025] - Trefis |
| 2026-02-05 | +6.0% | news | GlobeNewswire | Johnson Fistel, PLLP Investigates Claims on Behalf of - GlobeNewswire |
| 2025-05-08 | -5.8% | earnings | Seeking Alpha | Treace Medical Concepts GAAP EPS of -$0.25 beats by $0.05, revenue of $52.6M beats by $0.53M |
| 2025-05-08 | -5.8% | legal | SEC EDGAR | TMCI 8-K: 2.02 and (SEC Filing) |
| 2023-03-10 | -5.8% | legal | SEC EDGAR | TMCI 8-K: 8.01 (SEC Filing) |
| 2024-02-27 | -5.7% | legal | SEC EDGAR | TMCI 8-K: 2.02, 7.01 (SEC Filing) |
| 2026-04-23 | +5.5% | earnings | UBND thành phố Hải Phòng | TMCI (Treace Medical Concepts Inc.) notches narrow Q4 2025 EPS beat, shares rise 3.74 percent on positive investor sentiment. - Stock Community Signals - UBND thành phố Hải Phòng |
| 2026-04-21 | -5.4% | executive | Stock Titan | Treace Medical Concepts (TMCI) CFO reports 11,547-share tax withholding - Stock Titan |
| 2026-04-07 | -5.4% | news | GlobeNewswire | Treace Announces First Surgical Cases with the SuperBite™ Compression Screw System |
| 2026-04-07 | -5.4% | earnings | Stock Titan | New foot-and-ankle screw reaches first surgeries before Q3 launch - Stock Titan |
| 2026-04-07 | -5.4% | news | Cổng thông tin điện tử tỉnh Tây Ninh | Is Treace (TMCI) Stock slowing down | Price at $1.34, Down 6.94% - Institutional Grade Picks - Cổng thông tin điện tử tỉnh Tây Ninh |
| 2026-04-07 | -5.4% | news | Cổng thông tin điện tử Tỉnh Sơn La | Is Treace (TMCI) Stock slowing down | Price at $1.34, Down 6.94% - Cycle Analysis - Cổng thông tin điện tử Tỉnh Sơn La |
| 2023-05-08 | -5.1% | legal | SEC EDGAR | TMCI 8-K: 2.02 and (SEC Filing) |
| 2022-02-25 | +5.1% | legal | SEC EDGAR | TMCI 8-K: 5.02 (SEC Filing) |
| 2026-02-03 | -4.9% | news | Yahoo Finance | Reassessing The Narrative For Treace Medical Concepts (TMCI) After Target Cuts And Uneven Demand - Yahoo Finance |
| 2021-05-25 | +4.7% | legal | SEC EDGAR | TMCI 8-K: 2.02 and (SEC Filing) |
| 2024-04-24 | -4.7% | executive | Stock Titan | Treace Medical Named First Medical Device Partner and Official Foot and Ankle Solution Partner of the PPA Tour - Stock Titan |
| 2026-02-18 | +4.7% | news | Yahoo Finance | What Catalysts Are Shifting The Narrative For Treace Medical Concepts (TMCI)? - Yahoo Finance |
| 2025-08-10 | +4.4% | analyst | simplywall.st | Treace Medical Concepts, Inc. (NASDAQ:TMCI) Just Reported, And Analysts Assigned A US$8.35 Price Target - simplywall.st |
| 2025-03-04 | +4.3% | executive | Investing.com | Treace medical concepts CEO John Treace buys $524,064 in stock - Investing.com |
| 2026-04-17 | +4.3% | news | Simply Wall St. | How The Treace Medical Concepts (TMCI) Narrative Is Shifting With New Targets And Product Plans |
| 2026-04-17 | +4.3% | news | Yahoo Finance | How The Treace Medical Concepts (TMCI) Narrative Is Shifting With New Targets And Product Plans - Yahoo Finance |
| 2025-04-28 | +4.2% | news | GlobeNewswire | TREACE MEDICAL CONCEPTS, INC. (NASDAQ: TMCI) DEADLINE - GlobeNewswire |
| 2025-04-28 | +4.2% | news | Intellectia AI | TMCI Forecast — Price Prediction for 2026. Should I Buy TMCI? - Intellectia AI |
| 2025-06-27 | +4.2% | news | GlobeNewswire | Notice to Long-Term Shareholders of MicroStrategy, Inc. - GlobeNewswire |
| 2021-08-05 | -4.1% | legal | SEC EDGAR | TMCI 8-K: 2.02 and (SEC Filing) |
| 2025-07-17 | -4.0% | news | GlobeNewswire | Important Notice to Long-Term Shareholders of Centene - GlobeNewswire |
| 2026-02-13 | -3.9% | legal | DirectorsTalk Interviews | Treace Medical Concepts, Inc. (TMCI) Stock Analysis: Navigating a Potential 121% Upside in the Healthcare Sector - DirectorsTalk Interviews |
| 2025-02-28 | -3.8% | earnings | Seeking Alpha | Treace Medical Concepts, Inc. (TMCI) Q4 2024 Earnings Call Transcript |
| 2025-11-05 | -3.7% | earnings | Yahoo Finance | What To Expect From Treace Medical Concepts Inc (TMCI) Q3 2025 Earnings - Yahoo Finance |
| 2022-11-08 | +3.4% | legal | SEC EDGAR | TMCI 8-K: 2.02 and (SEC Filing) |
| 2021-10-04 | -3.4% | legal | SEC EDGAR | TMCI 8-K: 5.02 and (SEC Filing) |
| 2026-03-20 | -3.1% | analyst | Simply Wall St. | How The Story Is Shifting For Treace Medical Concepts (TMCI) After Analyst Target Resets |
| 2025-04-21 | -3.1% | news | GlobeNewswire | TREACE MEDICAL CONCEPTS, INC. (NASDAQ: TMCI) DEADLINE - GlobeNewswire |
| 2022-08-09 | -3.0% | legal | SEC EDGAR | TMCI 8-K: 2.02 and (SEC Filing) |
| 2026-01-13 | -2.9% | earnings | Seeking Alpha | Treace announces preliminary Q4 revenue between $62.1M to $62.5M |
| 2026-01-13 | -2.9% | legal | SEC EDGAR | TMCI 8-K: 2.02, 7.01 (SEC Filing) |
| 2026-01-13 | -2.9% | earnings | Quiver Quantitative | Treace Medical Concepts Reports Preliminary 2025 Revenue Results and Updates on Surgeon Adoption Trends - Quiver Quantitative |
| 2023-01-09 | +2.5% | legal | SEC EDGAR | TMCI 8-K: 2.02 and (SEC Filing) |
| 2024-08-06 | +2.4% | earnings | Seeking Alpha | Treace Medical Concepts GAAP EPS of -$0.34 misses by $0.05, revenue of $44.5M beats by $1.5M |
| 2024-08-06 | +2.4% | legal | SEC EDGAR | TMCI 8-K: 2.02 and (SEC Filing) |
| 2025-04-18 | +2.2% | legal | openPR.com | Lawsuit filed for Investors who lost money with shares of Treace Medical Concepts, Inc. (NASDAQ: TMCI) - openPR.com |
| 2025-05-11 | +2.2% | earnings | Seeking Alpha | Treace Medical Concepts, Inc. (TMCI) Q1 2025 Earnings Call Transcript |
| 2026-01-14 | -2.0% | news | Seeking Alpha | Treace Medical Concepts, Inc. (TMCI) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript |
| 2026-01-14 | -2.0% | news | Seeking Alpha | Treace Medical Concepts, Inc. (TMCI) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow |
| 2025-10-27 | -1.9% | news | GlobeNewswire | Important Notice to Long-Term Shareholders of Five Below, - GlobeNewswire |
| 2023-06-13 | +1.8% | legal | SEC EDGAR | TMCI 8-K: 2.01 and (SEC Filing) |
| 2025-12-18 | -1.8% | news | Seeking Alpha | Treace Medical announces up to $175M debt facility |
| 2025-12-18 | -1.8% | legal | SEC EDGAR | TMCI 8-K: 1.01, 1.02, 2.03, 3.03, 7.01, 8.01 (SEC Filing) |
| 2025-12-18 | -1.8% | expansion | Quiver Quantitative | Treace Medical Concepts Announces $175 Million Secured Loan Agreement to Enhance Financial Flexibility and Market Position | TMCI Stock News - Quiver Quantitative |
| 2026-04-19 | +1.7% | earnings | MarketBeat | Wall Street Zen Downgrades Treace Medical Concepts (NASDAQ:TMCI) to Strong Sell - MarketBeat |
| 2023-06-01 | -1.7% | legal | SEC EDGAR | TMCI 8-K: 7.01, 8.01 (SEC Filing) |
| 2022-09-28 | +1.7% | legal | SEC EDGAR | TMCI 8-K: 5.02 and (SEC Filing) |
| 2026-01-07 | +1.7% | news | simplywall.st | Why Investors Shouldn't Be Surprised By Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) Low P/S - simplywall.st |
| 2021-11-04 | -1.7% | legal | SEC EDGAR | TMCI 8-K: 2.02 and (SEC Filing) |
| 2025-09-04 | -1.6% | news | Seeking Alpha | Treace Medical Concepts, Inc. (TMCI) Investor Day 2025 Call Transcript |
| 2025-05-12 | -1.6% | news | GlobeNewswire | TREACE MEDICAL CONCEPTS, INC. (NASDAQ: TMCI) DEADLINE - GlobeNewswire |
| 2025-03-28 | +1.6% | news | Stock Titan | Breakthrough Clinical Results: Treace Bunion Surgery Achieves Near-Perfect Success Rate - Stock Titan |
| 2023-02-23 | -1.5% | legal | SEC EDGAR | TMCI 8-K: 5.02 (SEC Filing) |
| 2025-06-07 | +1.5% | legal | PR Newswire | INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Treace Medical Concepts, Inc of Class Action Lawsuit and Upcoming Deadlines - TMCI - PR Newswire |
| 2025-09-03 | -1.4% | analyst | Seeking Alpha | Treace Medical Concepts, Inc. (TMCI) Analyst/Investor Day - Slideshow |
| 2025-09-22 | -1.2% | legal | GlobeNewswire | Johnson Fistel, PLLP Continues Investigation on Behalf of - GlobeNewswire |
| 2026-04-22 | -1.2% | earnings | Cổng thông tin điện tử Tỉnh Sơn La | TMCI (Treace Medical Concepts Inc.) notches narrow Q4 2025 EPS beat, shares rise 3.74 percent on positive investor sentiment. - Top Analyst Buy Signals - Cổng thông tin điện tử Tỉnh Sơn La |
| 2026-04-22 | -1.2% | news | StocksToTrade | Treace Medical Concepts Inc. (TMCI) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade |
| 2026-04-03 | -1.2% | executive | Stock Titan | CFO at Treace Medical (TMCI) granted 100,000 performance stock units - Stock Titan |
| 2022-01-12 | +1.1% | legal | SEC EDGAR | TMCI 8-K: 2.02 and (SEC Filing) |
| 2025-04-17 | +1.0% | news | GlobeNewswire | TMCI Stockholder Notice: Robbins LLP Reminds Shareholders - GlobeNewswire |
| 2026-02-04 | -0.7% | news | simplywall.st | Institutional owners may consider drastic measures as Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) recent US$29m drop adds to long-term losses - simplywall.st |
| 2025-04-16 | -0.5% | legal | The Malaysian Reserve | Investor Alert: Robbins LLP Informs Investors of the Treace Medical Concepts, Inc. Class Action Lawsuit - The Malaysian Reserve |
| 2024-06-14 | +0.5% | news | Seeking Alpha | Treace Medical Concepts: Facing Increasing Competitive Pressure (NASDAQ:TMCI) - Seeking Alpha |
| 2025-12-30 | +0.5% | executive | Quiver Quantitative | Treace Medical Concepts CEO John T. Treace to Present at 44th Annual J.P. Morgan Healthcare Conference - Quiver Quantitative |
| 2023-02-10 | +0.5% | legal | SEC EDGAR | TMCI 8-K: 1.01, 8.01 (SEC Filing) |
| 2022-03-03 | +0.3% | legal | SEC EDGAR | TMCI 8-K: 2.02 and (SEC Filing) |
| 2024-12-29 | -0.3% | news | Yahoo Finance | With 54% institutional ownership, Treace Medical Concepts, Inc. (NASDAQ:TMCI) is a favorite amongst the big guns - Yahoo Finance |
| 2021-04-27 | +0.3% | legal | SEC EDGAR | TMCI 8-K: 5.03, 8.01 (SEC Filing) |
| 2026-01-20 | -0.2% | analyst | Yahoo Finance | How New Analyst Targets Are Reframing The Treace Medical Concepts (TMCI) Investment Story - Yahoo Finance |
| 2025-06-05 | +0.2% | news | Seeking Alpha | Zimmer Biomet sued for violating Treace Medical patents related to bunion treatment |
| 2026-02-24 | -0.1% | news | Stock Titan | New bunion surgery tools show patients back walking in days - Stock Titan |
| 2026-04-24 | — | news | GlobeNewswire | Treace to Report First Quarter 2026 Financial Results on May 8, 2026 |
| 2026-04-24 | — | news | Stock Titan | Before markets open May 8, Treace will post results and hold an 8 a.m. ET call - Stock Titan |
| 2026-04-24 | — | analyst | MSN | Treace Medical Concepts (TMCI) price target increased by 12.28% to 4.08 - MSN |